Skip to main content
SpringerLink
Log in

Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): Is it worth the risk?

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bishop J.E. Soaring medical costs and the Mayo “epidemic”. The Wall Street Journal 1980, 26.

    Google Scholar 

  2. Rao D.S. Primary hyperparathyroidism: changing patterns in presentation and treatment decisions in the Eighties. Henry Ford Hospital Med. J. 1985, 33: 194–197.

    CAS  Google Scholar 

  3. Rao D.S., Phillips E., Honasoge M., Mithal A., Mishra S.D., Singh A.K., Han Z.-H., Parikh N., Lee M., Talpos G.B. Role of vitamin D nutrition in primary hyperpa-rathyroidism: effect on parathyroid gland mass and on bone. In: Norman A.W., Boullion R., Thomasset M. (Eds.), Vitamin D: Chemistry, biology, and clinical applications of the steroid hormone. University of California-Riverside, Riverside, 1997, pp. 723–724.

    Google Scholar 

  4. Rao D.S., Honasoge M., Divine G.W., Phillips E.R., Lee M.W., Ansari M.R., Talpos G.B., Parfitt A.M. Effect of vitamin D nutrition on parathyroid ade noma weight: pathogenetic and clinical implica tions. J. Clin. Endocrinol. Metab. 2000, 85: 1054–1058.

    CAS  PubMed  Google Scholar 

  5. Rastad J. Parathyroidectomy for asymptomatic primary hyper-parathyroidism (PHPT): Is it worth the risk? J. Endocrinol. Invest. 2001, 23: 56–61.

    Article  Google Scholar 

  6. Parfitt A.M., Rao D.S., Kleerekoper M. Asymptomatic primary hyperparathyroidism dis covered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J. Bone Miner. Res. 1991, 6: S97–S101.

    Article  PubMed  Google Scholar 

  7. Rao D.S., Wilson R.J., Kleerekoper M., Parfitt A.M. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J. Clin. Endocrinol. Metab. 1988, 67: 1294–1298.

    Article  CAS  PubMed  Google Scholar 

  8. Wilson R.J., Rao D.S., Ellis B., Kleerekoper M., Parfitt A.M. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann. Intern. Med. 1988, 109: 959–962.

    Article  CAS  PubMed  Google Scholar 

  9. Proceedings of the NIH consensus development con ference on diagnosis and management of asymp tomatic primary hyperparathyroidism. J. Bone Miner. Res. 1991, 6: S9–S13.

  10. Kleerekoper M., Rao D.S., Talpos G.B., Bone H.G. Management of asymptomatic primary hyperpara- thyroidism. Adv. Endocrinol. Metab. 1991, 2: 205–220.

    Google Scholar 

  11. Silverberg S.J., Gartenberg F., Jacobs T.P., Shane E., Siris E., Staron R.B., Bilezikian J.P. Longitudinal measurements of bone density and biochemical indices in untreated primary hyper- parathyroidism. J. Clin. Endocrinol. Metab. 1995, 80: 723–728.

    CAS  PubMed  Google Scholar 

  12. Silverberg S.J., Shane E., Jacobs T.P., Siris E., Bilezikian J.P. A 10-year prospective study of primary hyper-parathyroidism with or without parathyroid surgery. N. Engl. J. Med. 1999, 341: 1249–1255.

    Article  CAS  PubMed  Google Scholar 

  13. Silverberg S.J., Locker F.G., Bilezikian J.P. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1996, 81: 4007–4012.

    CAS  PubMed  Google Scholar 

  14. Palmer M., Bergstrom R., Akerstrom G., Adami H., Jakobsson S., Ljunghall S. Survival and renal function in untreated hypercal-cemia: population-based cohort study with 14 years of follow-up. Lancet 1987, 1: 59–62.

    Article  CAS  PubMed  Google Scholar 

  15. Posen S., Clifton-Bligh P., Reeve T.S., Wagstaffe C., Wilkinson M. Is parathyroidectomy of benefit in primary hyper-parathyroidism? Q. J. Med. 1985, 54: 241–251.

    CAS  PubMed  Google Scholar 

  16. Dauphine R.T., Riggs B.L., Scholz D.A. Back pain and vertebral crush fractures: an unem-phasized mode of presentation for primary hyper-parathyroidism. Ann. Intern. Med. 1975, 83: 365–367.

    Article  CAS  PubMed  Google Scholar 

  17. Larsson K., Lindh E., Persson I., Ljunghall S. Increased fracture risk in hypercalcemia: bone mineral content measured in hyperparathyroidism. Acta. Orthop. Scand. 1989, 60: 268–270.

    Article  CAS  PubMed  Google Scholar 

  18. Melton L.J.I., Atkinson E.J., O’Fallon M., Heath H.I. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch. Intern. Med. 1992, 152: 2269–2273.

    Article  PubMed  Google Scholar 

  19. Khosla S., Melton L.J.I., Wermers R.A., Crowson C.S., O’Fallon M., Riggs B.L. Primary hyperparathyroidism and the risk of fracture: a population-based study. J. Bone Miner. Res. 1999, 14: 1700–1707.

    Article  CAS  PubMed  Google Scholar 

  20. Rao D.S., Phillips E., Jacobsen G., Divine G. Natural history of untreated mild primary hyperpara-thyroidism (PHPT): First five year results of a prospective clinical study. J. Bone Miner. Res. 1994, 9: S423.

    Google Scholar 

  21. Rao D.S., Phillips E.R., Divine G.W., Talpos G.B. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic prima ry hyperparathyroidsm: Final report. J. Bone Miner. Res. 2000, 15: S164.

    Google Scholar 

  22. Barletta G., De Feo M.L., Del Bene R., Lazzeri C., Vecchiarino S., La Villa G., Brandi M.L., Franchi F. Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 2000, 85: 1815–1821.

    CAS  PubMed  Google Scholar 

  23. Rao D.S., Alam M., Maciejko J.J., Phillips E., Divine G.W., Talpos G.B. Cardiac function and lipid profile in mild asymptomatic primary hyperparathyroidism: effect in a randomized trial of parathyroidectomy. Bone 1998, 23: S380.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone and Mineral Division, Bone & Mineral Research Laboratory, Henry Ford Hospital, 2799 W. Grand Blvd., Detroit, MI, 48202-2608, USA

    D. Sudhaker Rao

  2. Case Western Reserve University, Cleveland, USA

    D. Sudhaker Rao

Authors
  1. D. Sudhaker Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Sudhaker Rao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sudhaker Rao, D. Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): Is it worth the risk?. J Endocrinol Invest 24, 131–134 (2001). https://doi.org/10.1007/BF03343826

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343826

Key-words

Search

Navigation